Encyclopedia

  • Chapter 10 - Nanotherapeutics: A Novel and Powerful Approach in Modern Healthcare System
  • Add time:09/05/2019         Source:sciencedirect.com

    Nanotherapeutics made revolutionary changes in healthcare as well as provide a vision to empower diagnostics and treatment strategies because of its ability to control the release of enclosed bioactive compound. It has gained special attention in modern medical research because of its potential for revolutionary applications in gene therapy, drug modification, drug delivery, and in vivo analysis. Because of the multifunctional characteristics of nanomaterials, which are the main structural constituents of the nanotherapeutic system, it has been found that there is wide scope of nanomaterials in therapeutics and diagnostics, where they are capable to overcome problems associated with current therapeutic systems. With the advancement in the synthesis procedure of nanomaterials, modern nanotherapeutic system has been achieved that can provide better effectiveness with less or no toxic effects. In view of such recent developments in modern therapeutic technologies, the chapter has been drafted highlighting the role of nanomaterials in surface design, bioconjugation, and therapeutic effect enhancement in modern nanotherapeutic systems. It is evident to document the current developments in the area of nanotherapeutics; considering these points, the chapter surveyed the basic principle of nanotherapeutic system, its design, and therapeutic applications. An overlook of various nanotherapeutics structures such as dendrimers, nanocapsules, solid lipid nanoparticle, nanoemulsion, and nanogels is discussed with their possible medical applications. At the end of this chapter, we have summarized the current trends of nanotherapeutics followed by future prospective of nanotherapeutics.

    We also recommend Trading Suppliers and Manufacturers of 5-ethylamino-9-diethylaminobenzo(a)phenothiazinium (cas 136825-96-2). Pls Click Website Link as below: cas 136825-96-2 suppliers


    Prev:Vibrational spectroscopic (FT-IR and FT-Raman) studies, HOMO–LUMO, NBO analysis and MEP of 6-methyl-1-({[(2E)-2-methyl-3-phenyl-prop-2-en-1-yl]oxy}methyl)-1,2,3,4-tetra-hydroquinazoline-2,4-dione, a potential chemotherapeutic agent, using density functional methods
    Next: ReviewVeterinary photodynamic therapy: A review)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View